Oss, Netherlands

Willem Hendrik Abraham Dokter

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Willem Hendrik Abraham Dokter. Retrieved from https://idiyas.com/inventor/willem-hendrik-abraham-dokter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Willem Hendrik Abraham Dokter: Innovator in Glucocorticoid Modulation

Introduction

Willem Hendrik Abraham Dokter is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal glucocorticoid receptor modulators. His work is essential for advancing therapeutic options in various medical conditions.

Latest Patents

Dokter holds a patent for non-steroidal glucocorticoid receptor modulators. The patent describes compounds having a general Formula (I) or a pharmaceutically acceptable salt thereof. It also covers pharmaceutical compositions that include these compounds and their use in modulating glucocorticoid receptor activity.

Career Highlights

Willem Hendrik Abraham Dokter is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck has allowed him to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Throughout his career, Dokter has collaborated with several professionals, including Ralf Plate and Guido Jenny Rudolf Zaman. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Willem Hendrik Abraham Dokter is a prominent figure in the field of pharmaceutical innovation, particularly in glucocorticoid receptor modulation. His contributions through patents and collaborations continue to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…